The obesity duopoly has been pierced as Amgen positions itself to have a drug on the market in a few years. While this adds ...

The biotech industry can be volatile even for relatively large companies. Amgen ( AMGN 1.00%), one of the more prominent names in the game, just reminded us all of that fact. On Nov. 26, the company's ...

Novocure stock catapulted early Monday after the company's cancer-treating device succeeded in a study of patients with pancreatic cancer.

Unless you have been living under a rock, you’ll know that anti-obesity GLP-1 drugs are the next big thing in pharma, with ...

Using tumor-treating fields alongside chemotherapy improved patient survival, Novocure said. Elsewhere, Cytokinetics got a ...

Novartis will pay PTC Therapeutics up to $2.9 billion in a licensing deal for its Huntington's treatment. PTC Therapeutics stock surged.

Robert F. Kennedy Jr. has been a crusader for decades, first for the environment and then about vaccines, often clashing with ...

Around 50 people are feared to have been killed following clashes between fans and a stampede that ensued on Sunday during a ...

Armed with results from a phase 2 trial, Boehringer Ingelheim has said it will take its obesity drug candidate survodutide into a phase 3 programme later this year. The glucagon/GLP-1 receptor ...

Microsoft Corporation, Oracle Corporation, BP PLC, Novo Nordisk A/S Class B. Read Edison Group (Joanne Collins)'s latest article on Investing.com UK.

Many of us have felt it, and now it's official: "brain rot" is the Oxford dictionaries' word of the year. "It's not very comfortable being trapped in (your body) because it just doesn't feel like ...

Hailing from Belgharia in Kolkata, 22-year-old Sayan Ghosh had traveled to Bangladesh on November 23. He stayed with a friend’s family.